
After total hip or knee arthroplasty, aspirin alone was noninferior to rivaroxaban followed by aspirin in preventing symptomatic venous thromboembolism, with a similarly low risk of bleeding complications. Full EPCAT III trial results and Research Summary: nej.md/44j0Bne

























